Phenotyping technologies save on costs and improve rare disease workflows
Dekel Gelbman, CEO of FDNA, was featured in Becker’s Hospital Review, discussing the value of phenotyping to hospitals involved in…
Articles, insights, and posts about Child Development, early detection, and new methods in diagnosis and treatment.
Dekel Gelbman, CEO of FDNA, was featured in Becker’s Hospital Review, discussing the value of phenotyping to hospitals involved in…